Evidence map›Paper›PMID 26729828›Full record

ArticleBMJ case reports2016

Genetic predisposition resulting in sinusoidal obstruction syndrome in a patient with resected sigmoid cancer on adjuvant oxaliplatin.

Si Xuan Koo, Sock Hoai Chan, Joanne Ngeow

Abstract readCase Reports
In one paragraph

Article in BMJ case reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Si Xuan KooDepartment of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
Sock Hoai ChanNational Cancer Centre Singapore, Singapore, Singapore.
Joanne NgeowNational Cancer Centre Singapore, Singapore, Singapore.ORCID http://orcid.org/0000-0003-1558-3627
National Cancer Centre Singapore · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A Chinese man who had undergone a curative high anterior resection for sigmoid cancer was administrated XELOX (capecitabine and oxaliplatin) as postoperative adjuvant chemotherapy. He subsequently developed sinusoidal obstruction syndrome (SOS) that resolved on discontinuation of XELOX treatment. Genetic evaluation determined that he had the GSTT1-null and GSTM1-null genotype, known to be an independent risk factor for developing oxaliplatin-induced SOS.

Indexed as

Genetic Predisposition to DiseaseAntineoplastic Combined Chemotherapy ProtocolsCapecitabineChemotherapy, AdjuvantDeoxycytidineFluorouracilGlutathione TransferaseHepatic Veno-Occlusive DiseaseHumansMaleMiddle AgedOrganoplatinum CompoundsOxaliplatinOxaloacetatesSigmoid NeoplasmsCapecitabineDeoxycytidineFluorouracilglutathione S-transferase T1Glutathione TransferaseOrganoplatinum CompoundsOxaliplatinOxaloacetates

Identifiers

PMID26729828
PMCPMC4716373
OpenAlexW2224938371

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.